J&J Hit With $1.8M Verdict In Levaquin MDL

Law360, New York (December 8, 2010, 8:08 PM EST) -- A federal jury on Wednesday awarded $1.8 million to a Minnesota man who claimed that taking Johnson & Johnson's antibiotic Levaquin to treat a respiratory infection contributed to tears in his Achilles tendon.

A jury in the U.S. District Court for the District of Minnesota hit J&J unit Ortho-McNeil-Janssen Pharmaceuticals Inc. with $700,000 in actual damages and nearly $1.1 million in punitive damages for acting with deliberate disregard for the rights and safety of others in marketing the drug, in two separate special verdicts handed down...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.